Le Lézard
Classified in: Health
Subject: SVY

In-vitro Diagnostics (IVD) Regulations Course: A Systematic Approach from Regulatory Strategy to Regulatory Approvals in U.S./Europe/Canada (Boston, United States - October 14-15, 2019)


DUBLIN, Sept. 23, 2019 /PRNewswire/ -- The "Navigating through the Maze of In-vitro Diagnostics (IVD) Regulations: A Systematic Approach from Regulatory Strategy to Regulatory Approvals in U.S./Europe/Canada" conference has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This 2 day interactive course on in-vitro diagnostics is structured to understand the different set of IVD regulations, how to navigate through this maze of IVD regulations, and to win regulatory approvals. This In-vitro Diagnostics (IVD) course will make the attendees understand the IVD regulations and develop regulatory strategies that secure regulatory approvals.

In-vitro Diagnostics (IVD) products provide critical information on patient's health condition, based on which the healthcare provider develops and administers treatment plan. Although IVDs are medical devices, they are regulated under a separate set of regulations in U.S., Europe, and Canada.

Learning Objectives:

After completion of this two day interactive course on IVD, the attendee will be able to:

Who Should Attend:

This interactive course is specifically developed for individuals, who are responsible for the design, development, manufacturing, marketing, and distribution of IVD products.

This course is highly recommended for personnel involved in any of the following functions:

Agenda:

Day 1

Session 1: 09:00 AM - 10:30 AM

Morning Break: 10:30 AM - 10:45 AM

Session 2: 10:45 AM - 12:15 PM

Lunch Break: 12:15 PM - 1:15 PM

Session 3: 1:15 PM - 2:45 PM

Afternoon Break: 02:45 PM - 03:00 PM

Session 4: 03:00 PM - 04:30 PM

Day 2

Session 5: 09:00 AM - 10:30 AM

Morning Break: 10:30 AM - 10:45 AM

Session 6: 10:45 AM - 12:15 PM

Lunch Break: 12:15 PM - 1:15 PM

Session 7: 1:15 PM - 2:45 PM

Afternoon Break: 02:45 PM - 03:00 PM

Session 8: 03:00 PM - 04:30 PM

For more information about this conference visit https://www.researchandmarkets.com/r/ma8c0q

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: